Precise Bio

Bio-fabricated Tissues and Organs

Health Tech & Life Sciences
Active
Series B Modi'in-Maccabim-Re'ut Founded 2015
Total raised
$22.0M
Last: Undisclosed 2024-09
Stage
Series B
Founded
2015
Headcount
42
HQ
Modi'in-Maccabim-Re'ut
Sector
Health Tech & Life Sciences

About

Precise Bio is a regenerative medicine company advancing the use of bio-printed tissues and organs in ophthalmology patients. The company is also building a broad portfolio of R&D programs in additional medical disciplines. The company's commercial and R&D programs are based on its 4D bio-fabrication technology. This platform comprises cell expansion, biomaterials, processes, printing technology, and other technologies. The company's technology platform allows it to advance its fabricated human cornea program concurrent with the development of other organs and tissues for use in ophthalmic indications. Moreover, the company's technology overcomes multiple challenges in scalable, reproducible manufacturing of bio-printed tissues and organs. The company maintains offices, laboratories, and production facilities in North Carolina, United States, and Shoham, Israel.

Funding history · 4 rounds · $22.0M total

2024-09
Undisclosed Undisclosed
2022-07
Series B $12.0M
2022-07
Debt Financing $15.5M
2017-09
Series A $10.0M

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue Engineering
Technologies
Materials & SubstancesPlatforms & InterfacesBiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesBiotechnology
Business model
B2B

Tags

ophthalmologytreatmentsbiotechnology3d-technologyregenerative-medicinelife-sciencesbiomaterialsmedical-technologiestissue-regeneration